Select Page

The Foundation of Sarcoidosis Research (FSR) maintains a strong Scientific Advisory Board (SAB) composed of world renowned key opinion leaders within the fields of sarcoidosis, medical research, therapy development, and medical practice. The SAB helps advance FSR towards its mission dedicated to finding a cure for this disease and to improving care for sarcoidosis patients.

Elliott Crouser, MD

SAB Chair

Ohio State University


Robert Baughman, MD


John Belperio, MD

UCLA Medical Center


Edward Chen, MD

Johns Hopkins University


Ulrich Costabel, MD, FERS

University of Duisburg-Essen


Wonder Drake, MD

Vanderbilt University


Marjolein Drent, MD, PhD

St. Antonius Hospital


Andrew Fontenot, MD

University of Colorado


Skip Garcia, MD

University of Arizona

Ennis James, MD

Medical University of South Carolina


Craig Lipset

Managing Partner

Clinical Innovation Partners


Lisa Maier, MD, MSPH, FCCP

National Jewish Health


Adam Morgenthau, MD

Icahn School of Medicine at Mount Sinai


Ogugua Obi, MD, MPH, MSc

East Carolina University


Misha Rosenbach, MD

University of Pennsylvania


Milton Rossman, MD

University of Pennsylvania


Barney Stern, MD

University of Maryland


Dominique Valeyre, MD

Hôpital Avicenne

Please note: While FSR receives guidance and input from our Scientific Advisory Board (SAB), it is not to be implied that all SAB members support or are in agreement in each specific FSR initiative or approach. As with most professional groups, members may have differing perspectives and opinions on various issues. FSR’s intent is always to work toward consensus with our experts as much as feasible while addressing patient and research needs.


Meet our staff.

Translate »